News | April 14, 2025
Nureca’s manufacturing subsidiary secures USFDA registration
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
Experts urge early detection & better access to care
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring
Metoprolol Tartrate and Hydrochlorothiazide Tablet is the combination tablet of metoprolol tartrate, a beta adrenoceptor blocker and hydrochlorothiazide (HCTZ), a thiazide diuretic, indicated for the treatment of hypertension, to lower blood pressure
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
The company reported total income at Rs. 509.8 crore in Q1 FY25 as compared to Rs. 570.3 crore in Q1 FY24
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
Subscribe To Our Newsletter & Stay Updated
